Supplementary
. Abrogation of NMD does not elicit latent splicing in the wild-type CAD1 pre-mRNA. Human 293T cells were cotransfected with the indicated plasmids and treated with 20 µg/ml of CHX for 2 hr (lanes 2 and 4). β-globin, wild type β-globin; β-globin Ter39, a mutant construct expressing β-globin mRNA having a PTC at position 39; CAD1, wildtype CAD1. The splicing patterns of CAD1, β-globin and GFP were revealed by RT-PCR. Abrogation of NMD by the CHX treatment is evidenced by the upregulation of β-globin Ter39 mRNA (compare lanes 3 and 4) whereas latent splicing in CAD1 mRNA is not elicited by this treatment (lanes 2 and 4).
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Supplementary Figure 2S
Sensitivity of detection of latent splicing
Because we could not detect any latent mRNA from the wild-type constructs (harboring in-frame stop codons upstream of the latent 5' splice site), we further evaluated the sensitivity of the realtime RT-PCR procedure. To this end we analyzed the presence of latent mRNA in a serial dilutions of RNA expressed from CAD2 Mut1, a construct already established for the expression of latent mRNA. As can be seen in the dissociation curve in Figure 2Sa , all reactions except for the 10 -4 -sample, produced one product corresponding to the latent mRNA. The amplification reactions were monitored (Figure 2Sb I ) and plotted to create a standard curve based on the relative expected levels of latent mRNA, as predicted for the serial dilutions (Figure 2Sb . Quantitation data for cycling of CAD2-Mut1 serial dilution Serial dilutions of the cDNA from CAD2 Mut1 mRNA were carried out as described above, and fluorescence was analyzed and plotted to a log scale. The florescence readings were then used to produce a standard curve to verify the reaction efficiency and accuracy of the dilution steps. The resulting efficiency was 1.98, the slope -3.363 and R 2 is 0.99933.
